LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway

Ming Zhang(Hunan Institute of Science and Technology), Lin Zhao(Dalian Medical University)
Journal of Experimental & Clinical Cancer Research
January 25, 2021
Cited by 50


Related Papers